Literature DB >> 15084692

Assisted reproductive technology in the United States.

Robert W Rebar1, Alan H DeCherney.   

Abstract

Keywords:  Genetics and Reproduction

Mesh:

Year:  2004        PMID: 15084692     DOI: 10.1056/NEJMp048046

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Local signalling environments and human male infertility: what we can learn from mouse models.

Authors:  Roopa L Nalam; Martin M Matzuk
Journal:  Expert Rev Mol Med       Date:  2010-05-11       Impact factor: 5.600

2.  Prognostic value of three pro-nuclei (3PN) incidence in elective single blastocyst-stage embryo transfer.

Authors:  Mingzhao Li; Wanqiu Zhao; Wei Li; Xiaoli Zhao; Juanzi Shi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Genome-wide analysis identifies changes in histone retention and epigenetic modifications at developmental and imprinted gene loci in the sperm of infertile men.

Authors:  Saher Sue Hammoud; David A Nix; Ahmad O Hammoud; Mark Gibson; Bradley R Cairns; Douglas T Carrell
Journal:  Hum Reprod       Date:  2011-06-17       Impact factor: 6.918

4.  Ethical Problems with Infertility Treatments: Attitudes and Explanations.

Authors:  Karina M Shreffler; David R Johnson; Laurie K Scheuble
Journal:  Soc Sci J       Date:  2010-12-01

Review 5.  Assisted reproductive technology in China: compliance and non-compliance.

Authors:  Jie Qiao; Huai L Feng
Journal:  Transl Pediatr       Date:  2014-04

6.  The effect of single embryo transfer on perinatal outcomes in Japan.

Authors:  Masako Hayashi; Shoji Satoh; Yoshio Matsuda; Akihito Nakai
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

7.  Dropout of infertility treatments and related factors among infertile couples.

Authors:  Maryam Ghorbani; Fatemeh Sadat Hosseini; Masud Yunesian; Afsaneh Keramat
Journal:  Reprod Health       Date:  2020-12-02       Impact factor: 3.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.